Clinical trial
Evaluation of Response to Clopidogrel in Patients With Essential Thrombocythemia
NCT07645755 is registered in ClinicalTrials.gov with Fondazione Policlinico Universitario Agostino Gemelli IRCCS as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Response to Clopidogrel in Patients With Essential Thrombocythemia
- Lead sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- July 15, 2026
- Completion date
- December 31, 2027
- Enrollment
- 50 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
essential thrombocythemia